menu
    • menu

    Company profile for Lyell Immunopharma

    NEW Drugs in Dev: 7
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality. We are focused on advancing the science of t-cell differentiation, functionality, and specificity so that we can develop curative treatments for human disease. We are all about the cells. Our team is comprised of world-class leaders and scientists united by one mission: to develop highly selective, curative cell-based immuno...
    Lyell Immunopharma Inc. is a cellular therapy company dedicated to mastering immune cell functionality. We are focused on advancing the science of t-cell differentiation, functionality, and specificity so that we can develop curative treatments for human disease. We are all about the cells. Our team is comprised of world-class leaders and scientists united by one mission: to develop highly selective, curative cell-based immunotherapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Lyell ImmunopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    SAN FRANCISCO, 400 East Janie Court Suite 301, South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://lyell.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/lyell
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lyell Presents Updated Ronde-Cel Safety Data at EHA 2026
    Lyell Presents Updated Ronde-Cel Safety Data at EHA 2026

    12 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/12/3311241/0/en/lyell-immunopharma-presents-updated-safety-data-and-translational-insights-for-rondecabtagene-autoleucel-ronde-cel-in-patients-with-large-b-cell-lymphoma-at-european-hematology-ass.html

    GLOBENEWSWIRE
    12 Jun 2026
    Share Share
    Lyell Updates LYL273 Safety in mCRC, Expands to Phase 1/2
    Lyell Updates LYL273 Safety in mCRC, Expands to Phase 1/2

    08 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/08/3307886/0/en/lyell-immunopharma-provides-update-on-safety-profile-of-lyl273-in-relapsed-or-refractory-metastatic-colorectal-cancer-and-amends-phase-1-trial-to-phase-1-2-expansion.html

    GLOBENEWSWIRE
    08 Jun 2026
    Share Share
    Lyell to Present Ronde-Cel Phase 1/2 Data for LBCL at EHA 2026
    Lyell to Present Ronde-Cel Phase 1/2 Data for LBCL at EHA 2026

    04 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/04/3307088/0/en/lyell-immunopharma-to-present-phase-1-2-safety-and-translational-data-for-ronde-cel-in-large-b-cell-lymphoma-at-the-european-hematology-association-2026-congress.html

    GLOBENEWSWIRE
    04 Jun 2026
    Share Share
    Lyell Immunopharma To Participate In Goldman Sachs Global Conf
    Lyell Immunopharma To Participate In Goldman Sachs Global Conf

    01 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/01/3304323/0/en/lyell-immunopharma-announces-participation-in-goldman-sachs-47th-annual-global-healthcare-conference-2026.html

    GLOBENEWSWIRE
    01 Jun 2026
    Share Share
    Lyell Immunopharma To Participate In May Investor Conferences
    Lyell Immunopharma To Participate In May Investor Conferences

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292761/0/en/lyell-immunopharma-announces-participation-in-may-investor-conferences.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Lyell Immunopharma Unveils Q1 2026 Business Highlights
    Lyell Immunopharma Unveils Q1 2026 Business Highlights

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289331/0/en/lyell-immunopharma-reports-business-highlights-and-financial-results-for-the-first-quarter-2026.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search